NICE has approved specific GLP-1 receptor agonists (semaglutide [Wegovy] in TA875 and liraglutide [Saxenda] in TA664) for weight management in eligible patients, subject to NHS local prescribing criteria
It bears the brunt of UV radiation, particulate pollution (a serious concern in cities like Delhi, Mumbai, and Bengaluru), and environmental toxins
Eli Lilly is conducting multiple phase 3 trials
The concept originated in early-phase drug development, where sub-therapeutic doses are given to study a drug's behavior in the body without producing clinical effects
It's designed to help your joints and muscles heal way faster
or secondary as a consequence of environmental factors and/or medications (shift work, spinal cord cervical transection, sympathectomy, aging, neurodegenerative diseases, genetic diseases, -blockers, calcium channel blockers, ACE inhibitors)